NeuroPace (NPCE) Fundamental Analysis: Revenue, Earnings & Valuation

0.81 / 10

Underperform

Fundamental assessment rates NPCE as Underperform (0.8/10). Profit‑to‑market value is modestly positive, yet cash‑to‑market, ROA, and profit margins are deeply negative, indicating poor profitability, weak cash position and limited asset quality.

Analysis Checks(3/10)

Revenue-MV

Value-1.10

Score2/3

Weight-16.38%

1M Return1.21%

ROA (%)

Value-21.44

Score1/3

Weight10.76%

1M Return-0.82%

Net cash flow from operating activities / Operating revenue (%)

Value-11.01

Score1/3

Weight16.96%

1M Return-1.35%

Profit-MV

Value0.66

Score2/3

Weight-48.75%

1M Return3.09%

Annualized net profit margin on total assets (%)

Value-21.44

Score1/3

Weight10.76%

1M Return-0.82%

EBIT / Total operating revenue (%)

Value-16.83

Score2/3

Weight-1.46%

1M Return0.10%

Asset-MV

Value-0.55

Score0/3

Weight42.41%

1M Return-3.44%

Net profit / Total operating revenue (%)

Value-21.47

Score1/3

Weight10.96%

1M Return-0.84%

Cash-MV

Value-3.61

Score1/3

Weight46.21%

1M Return-4.16%

Net profit / Total profit (%)

Value100.00

Score1/3

Weight28.54%

1M Return-2.39%

Is NPCE fundamentally strong?

NPCE scores 0.81/10 on fundamentals and holds a Premium valuation at present. Backed by its -158.74% ROE, -21.47% net margin, -22.07 P/E ratio, 24.89 P/B ratio, and 29.03% earnings growth, these metrics solidify its Underperform investment rating.